 Connection
Lisa Bero to Publishing
This is a "connection" page, showing publications Lisa Bero has written about Publishing.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
5.890 |
|
|
|
-
Grundy Q, Dunn AG, Bero L. Improving researchers' conflict of interest declarations. BMJ. 2020 Mar 11; 368:m422.
Score: 0.597
-
Ding D, Nguyen B, Gebel K, Bauman A, Bero L. Duplicate and salami publication: a prevalence study of journal policies. Int J Epidemiol. 2020 02 01; 49(1):281-288.
Score: 0.593
-
Chiu K, Grundy Q, Bero L. 'Spin' in published biomedical literature: A methodological systematic review. PLoS Biol. 2017 Sep; 15(9):e2002173.
Score: 0.502
-
Schroll J, Bero L. Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev. 2015 Apr 20; 4:ED000098.
Score: 0.425
-
Siler K, Lee K, Bero L. Reply to Margalida and Colomer: Science should strive to prevent mistakes, not corrections. Proc Natl Acad Sci U S A. 2015 Mar 31; 112(13):E1512.
Score: 0.422
-
Siler K, Lee K, Bero L. Measuring the effectiveness of scientific gatekeeping. Proc Natl Acad Sci U S A. 2015 Jan 13; 112(2):360-5.
Score: 0.416
-
Wolfe N, G?tzsche PC, Bero L. Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev. 2013 May 16; 2:31.
Score: 0.372
-
Walleser S, Hill SR, Bero LA. Characteristics and quality of reporting of cluster randomized trials in children: reporting needs improvement. J Clin Epidemiol. 2011 Dec; 64(12):1331-40.
Score: 0.328
-
Cook DM, Boyd EA, Grossmann C, Bero LA. Reporting science and conflicts of interest in the lay press. PLoS One. 2007 Dec 05; 2(12):e1266.
Score: 0.255
-
Parker L, Boughton S, Lawrence R, Bero L. Experts identified warning signs of fraudulent research: a qualitative study to inform a screening tool. J Clin Epidemiol. 2022 11; 151:1-17.
Score: 0.176
-
Mowatt G, Shirran L, Grimshaw JM, Rennie D, Flanagin A, Yank V, MacLennan G, G?tzsche PC, Bero LA. Prevalence of honorary and ghost authorship in Cochrane reviews. JAMA. 2002 Jun 05; 287(21):2769-71.
Score: 0.174
-
Lee KP, Schotland M, Bacchetti P, Bero LA. Association of journal quality indicators with methodological quality of clinical research articles. JAMA. 2002 Jun 05; 287(21):2805-8.
Score: 0.174
-
Turner SL, Karahalios A, Forbes AB, Taljaard M, Grimshaw JM, Cheng AC, Bero L, McKenzie JE. Design characteristics and statistical methods used in interrupted time series studies evaluating public health interventions: a review. J Clin Epidemiol. 2020 06; 122:1-11.
Score: 0.149
-
Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998 May 20; 279(19):1566-70.
Score: 0.132
-
Barnes DE, Bero LA. Scientific quality of original research articles on environmental tobacco smoke. Tob Control. 1997; 6(1):19-26.
Score: 0.120
-
Cho MK, Bero LA. The quality of drug studies published in symposium proceedings. Ann Intern Med. 1996 Mar 01; 124(5):485-9.
Score: 0.113
-
Bero L, Rennie D. The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA. 1995 Dec 27; 274(24):1935-8.
Score: 0.112
-
Mahady SE, Schlub T, Bero L, Moher D, Tovey D, George J, Craig JC. Side effects are incompletely reported among systematic reviews in gastroenterology. J Clin Epidemiol. 2015 Feb; 68(2):144-53.
Score: 0.101
-
Schroll JB, Bero L, G?tzsche PC. Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ. 2013 Apr 23; 346:f2231.
Score: 0.093
-
Bero LA, Ghersi D. Making systematic reviews global. Cochrane Database Syst Rev. 2011 Feb 16; (8):ED000020.
Score: 0.080
-
Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials. 2009 Dec 16; 10:116.
Score: 0.073
-
Hong MK, Bero LA. Tobacco industry sponsorship of a book and conflict of interest. Addiction. 2006 Aug; 101(8):1202-11.
Score: 0.058
-
Parker L, Boughton S, Bero L, Byrne JA. Paper mill challenges: past, present, and future. J Clin Epidemiol. 2024 Dec; 176:111549.
Score: 0.051
-
Hong MK, Bero LA. How the tobacco industry responded to an influential study of the health effects of secondhand smoke. BMJ. 2002 Dec 14; 325(7377):1413-6.
Score: 0.045
-
Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH. Comparison of review articles published in peer-reviewed and throwaway journals. JAMA. 2002 Jun 05; 287(21):2853-6.
Score: 0.044
-
Montini T, Mangurian C, Bero LA. Assessing the evidence submitted in the development of a workplace smoking regulation: the case of Maryland. Public Health Rep. 2002 May-Jun; 117(3):291-8.
Score: 0.043
-
Lexchin J, Bero LA, Davis C, Gagnon MA. Achieving greater independence from commercial influence in research. BMJ. 2021 03 09; 372:n370.
Score: 0.040
-
Bero LA, Rennie D. Influences on the quality of published drug studies. Int J Technol Assess Health Care. 1996; 12(2):209-37.
Score: 0.028
-
Hornbein T, Bero L, Rennie D. The publication of commercially supported supplements statement. Anesth Analg. 1995 Oct; 81(4):887-8; author reply 888-9.
Score: 0.027
-
Chang L, Dhruva SS, Chu J, Bero LA, Redberg RF. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports. BMJ. 2015 Jun 10; 350:h2613.
Score: 0.027
-
Cho MK, Bero LA. Instruments for assessing the quality of drug studies published in the medical literature. JAMA. 1994 Jul 13; 272(2):101-4.
Score: 0.025
-
Bero LA, Glantz SA, Rennie D. Publication bias and public health policy on environmental tobacco smoke. JAMA. 1994 Jul 13; 272(2):133-6.
Score: 0.025
-
Bero LA, Galbraith A, Rennie D. Sponsored symposia on environmental tobacco smoke. JAMA. 1994 Feb 23; 271(8):612-7.
Score: 0.025
-
Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, Thombs BD. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA. 2011 Mar 09; 305(10):1008-17.
Score: 0.020
-
Steinman MA, Bero LA, Chren MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006 Aug 15; 145(4):284-93.
Score: 0.015
-
Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003 May 31; 326(7400):1167-70.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|